NOVAVAX (NVAX) 11.58usd +8.73%
Shares of Novavax went high with almost nine percent today and it is trading on 11.58usd this is because Novavax is going to be announcing the results from its phase 3 clinical study evaluating Nanoparticle-based flu vaccine Nanoflu and the vaccine actually came out with positive results in its clinical trials. The vaccine is said to be more effective than any other flu vaccines that have been approved before and this is likely going to help in fighting the effects of Coronavirus. Traders and investors are actually are positive about the prospects for Novavax to report positive results from its late-stage study of experimental flu vaccine NanoFlu.